Heterocyclylalkylamines as muscarinic receptor antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 23, 2003
Grant Date -
Jan 10, 2002
app pub date -
May 22, 2001
filing date -
May 25, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention relates to compounds which are generally muscarinic M2/M3 receptor antagonists and which are represented by Formula I: ##STR1## wherein X, Y, and Z are O, S or NR.sup.5, and the other substituents are as defined in the specification; and prodrugs, individual isomers, racemic or non-racemic mixtures of isomers, and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds and methods for their use as therapeutic agents.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully